[Decision of the Department of Drugs of the National Board of Health and Welfare: indications for the use of clofibrate will be limited].
D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000009:adverse effects* / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control; D004341:Drug Evaluation; D006801:Humans; D013548:Sweden; D014944:World Health Organization
D002784:Cholesterol; D002994:Clofibrate
Beslut i socialstyrelsens läkemedelsavdelning: indikationerna för klofibrat begränsas.